| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 23.427 | 11.114 | 48.784 | 23.495 |
| Total Income - EUR | - | - | - | - | - | - | 23.427 | 11.114 | 48.784 | 23.495 |
| Total Expenses - EUR | - | - | - | - | - | - | 73 | 98 | 76 | 263 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 23.354 | 11.016 | 48.708 | 23.232 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 22.651 | 10.683 | 40.915 | 19.515 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Diabdocart S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 22.692 | 10.724 | 46.201 | 21.468 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 22.641 | 8.320 | 28.010 | 10.253 |
| Cash | - | - | - | - | - | - | 51 | 2.403 | 18.191 | 11.215 |
| Shareholders Funds | - | - | - | - | - | - | 22.692 | 10.724 | 40.955 | 19.723 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 0 | 0 | 5.246 | 1.745 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Diabdocart S.r.l.